Paxlovid efficacy and safety confirmed in trial

6 minute read


Treatment with nirmatrelvir / ritonavir in early covid shown to reduce progression to severe disease or death.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×